An immunosuppressive microenvironment in AML is driven by PD-L1 expression, kynurenine pathway activation, and low vitamin D levels. These findings suggest potential immunotherapeutic targets and highlight vitamin D's immunomodulatory role.
Choudhary et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: